Speaker

Robin Kleiman has >20 years of neuroscience drug discovery leadership. She is vice president and head of CNS Biology at Alkermes and was previously executive director of Human Cell and Molecular Biology at Biogen. She established the Translational Cellular Sciences group at Biogen to support testing of therapeutic molecules using iPSC derived cell types. Prior to Biogen, Robin spent 12 years at Pfizer in the Neuroscience Research Unit in various leadership roles and later moved to Boston Children’s Hospital to help establish the Translational Neuroscience Center and Human Neuron Core to operationalize systematic assay development and screening with patient derived iPSC neurons.

« Go Back